These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 8111727)
21. Studies of interaction of trichloro{eta2-cis-N,N-dimethyl-1-[6-(N',N'-dimethyl-ammoniummethyl)-cyclohex-3-ene-1-yl]-methylammonium}platinum(II) chloride with DNA: Effects on secondary and tertiary structures of DNA. Cytotoxic assays on human ovarian cancer cell lines, resistant and non-resistant to cisplatin. Gay M; Montaña AM; Moreno V; Prieto MJ; Pérez JM; Alonso C Bioorg Med Chem; 2006 Mar; 14(5):1565-72. PubMed ID: 16256352 [TBL] [Abstract][Full Text] [Related]
22. Radiosensitizing and toxic properties of quinoline and nitroquinoline complexes of platinum [PtCl2(NH3)quinoline]. Skov KA; Adomat H; Doedee M; Farrell N Anticancer Drug Des; 1994 Apr; 9(2):103-17. PubMed ID: 8166927 [TBL] [Abstract][Full Text] [Related]
23. Interaction of two second generation platinum antitumor drugs with mouse thymocytes. Simpkins H; Pearlman LF Cancer Res; 1986 Mar; 46(3):1433-9. PubMed ID: 3510724 [TBL] [Abstract][Full Text] [Related]
24. [Platinum complexes as radiosensitizers in radiotherapy]. López Zúmel MC; Alvarez MV; Santos Peinado L Rev Esp Oncol; 1984; 31(2):227-36. PubMed ID: 6100707 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and in vitro antitumor activity of platinum acetonimine complexes. Boccarelli A; Intini FP; Sasanelli R; Sivo MF; Coluccia M; Natile G J Med Chem; 2006 Jan; 49(2):829-37. PubMed ID: 16420068 [TBL] [Abstract][Full Text] [Related]
26. Chemical, biochemical and pharmacological activity of the novel sterically hindered platinum co-ordination complex, cis-[amminedichloro(2-methylpyridine)] platinum(II) (AMD473). Holford J; Raynaud F; Murrer BA; Grimaldi K; Hartley JA; Abrams M; Kelland LR Anticancer Drug Des; 1998 Jan; 13(1):1-18. PubMed ID: 9474239 [TBL] [Abstract][Full Text] [Related]
27. DNA polymerase zeta accounts for the reduced cytotoxicity and enhanced mutagenicity of cisplatin in human colon carcinoma cells that have lost DNA mismatch repair. Lin X; Trang J; Okuda T; Howell SB Clin Cancer Res; 2006 Jan; 12(2):563-8. PubMed ID: 16428501 [TBL] [Abstract][Full Text] [Related]
28. Interaction of metallothionein-2 with platinum-modified 5'-guanosine monophosphate and DNA. Karotki AV; Vasák M Biochemistry; 2008 Oct; 47(41):10961-9. PubMed ID: 18803406 [TBL] [Abstract][Full Text] [Related]
29. Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours. Goddard PM; Orr RM; Valenti MR; Barnard CF; Murrer BA; Kelland LR; Harrap KR Anticancer Res; 1996; 16(1):33-8. PubMed ID: 8615631 [TBL] [Abstract][Full Text] [Related]
30. The formation of DNA interstrand cross-links by a novel bis-[Pt2Cl4(diminazene aceturate)2]Cl4.4H2O complex inhibits the B to Z transition. González VM; Fuertes MA; Jiménez-Ruíz A; Alonso C; Pérez JM Mol Pharmacol; 1999 Apr; 55(4):770-7. PubMed ID: 10101036 [TBL] [Abstract][Full Text] [Related]
31. The effect of antitumor trans-[PtCl2(E-iminoether)2] on B-->Z transition in DNA. Zaludová R; Natile G; Brabec V Anticancer Drug Des; 1997 Jun; 12(4):295-309. PubMed ID: 9199661 [TBL] [Abstract][Full Text] [Related]
32. Different binding to DNA of enantiomeric platinum complexes assessed by inhibition of restriction enzyme activity. Coluccia M; Giordano D; Loseto F; Intini FP; Maresca L; Natile G Anticancer Res; 1989; 9(3):795-8. PubMed ID: 2548438 [TBL] [Abstract][Full Text] [Related]
33. Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatin-induced DNA interstrand cross-links and cytotoxicity in human glioblastoma cells. Ali-Osman F; Berger MS; Rajagopal S; Spence A; Livingston RB Cancer Res; 1993 Dec; 53(23):5663-8. PubMed ID: 8242621 [TBL] [Abstract][Full Text] [Related]
34. DNA interactions of new antitumor platinum complexes with trans geometry activated by a 2-metylbutylamine or sec-butylamine ligand. Prokop R; Kasparkova J; Novakova O; Marini V; Pizarro AM; Navarro-Ranninger C; Brabec V Biochem Pharmacol; 2004 Mar; 67(6):1097-109. PubMed ID: 15006546 [TBL] [Abstract][Full Text] [Related]
35. In vitro effect of Pt and Pd mercaptopyridine complexes. Carrara M; Berti T; D'Ancona S; Cherchi V; Sindellari L Anticancer Res; 1997; 17(2A):975-80. PubMed ID: 9137437 [TBL] [Abstract][Full Text] [Related]
36. Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles. Dedon PC; Borch RF Biochem Pharmacol; 1987 Jun; 36(12):1955-64. PubMed ID: 2954556 [TBL] [Abstract][Full Text] [Related]
37. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin. O'Neill CF; Koberle B; Masters JR; Kelland LR Br J Cancer; 1999 Dec; 81(8):1294-303. PubMed ID: 10604725 [TBL] [Abstract][Full Text] [Related]
38. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity. Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355 [TBL] [Abstract][Full Text] [Related]
39. Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters. Samimi G; Howell SB Cancer Chemother Pharmacol; 2006 Jun; 57(6):781-8. PubMed ID: 16170571 [TBL] [Abstract][Full Text] [Related]
40. [Molecular and cellular aspects of cis-diamminedichloroplatinum (II) interactions with DNA]. Zastawny TH; Oliński R Postepy Hig Med Dosw; 1993; 47(2):103-23. PubMed ID: 8415320 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]